Real-time enrollment status for this sickle cell disease vaso-occlusive crisis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:45 AM UTC
| NCT Number | NCT06699849 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease Vaso-occlusive Crisis |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 16 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of July 13, 2026: Clinical trial NCT06699849 is currently recruiting participants. This clinical trial study for sickle cell disease vaso-occlusive crisis is actively seeking new participants at 16 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06699849 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06699849 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.